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Background: Hepatitis B virus (HBV) is endemic worldwide. Given significant rates of infectivity, all infants born to
Hepatitis B surface antigen positive mothers need to receive treatment at birth, immunization and post-vaccination
serologic testing. However, not all infants complete these requirements.
Findings: We performed a retrospective review of the management of infants born to Hepatitis B infected mothers
at two large military hospitals in the United States that use a global electronic medical record to track patient
results. We then compared these results to those recently published by the National Perinatal Hepatitis B
Prevention Program (PHBPP), which does not include hospitals in the United States Military Healthcare System.
Our results show that although all infants were managed appropriately at birth and immunization rates were very
high, post vaccination follow-up testing rates were much lower than those seen in centers participating in the PHBPP.
The rates of post vaccination serological testing were significantly higher for infants born to Hepatitis B e antigen
positive mothers and those referred to a pediatric infectious disease specialist.
Conclusions: Despite use of a global electronic medical record in the United States Military Healthcare System,
management of HBV-exposed infants does not always follow recommended guidelines. These infants could benefit
from a more systematic method of follow-up, similar to the PHBPP, to ensure HBV serologic testing is obtained
after the vaccination series is complete.
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Background
The estimated number of annual births to Hepatitis B
surface antigen (HBsAg) positive women in the United
States has been steadily increasing [1]. The incidence of
perinatal HBV acquisition from HBsAg positive/Hepa-
titis B e antigen (HBeAg) positive mothers is greater
than 90% [2], and >50% amongst unvaccinated but
chronically exposed infants and toddlers [3], but with
proper treatment this rate may be reduced to 10-15%.
Although much lower, there is also a significant risk of
perinatal HBV acquisition from HBsAg positive/HBeAg
negative mothers. The National Perinatal Hepatitis B
Prevention Program (PHBPP) recently published their
data analyzing the effectiveness of their interventions
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reproduction in any medium, provided the orStates Military Healthcare System (MHS), with its uni-
fied global electronic medical record (EMR), compares
to the PHBPP in managing newborns who are at risk of
acquiring HBV.
Materials and methods
We performed a retrospective review of the manage-
ment of infants born to Hepatitis B infected mothers at
two of the largest military treatment facilities: Tripler
Army Medical Center in Honolulu, Hawaii and Madigan
Healthcare System in Tacoma, Washington. Cases were
identified between September 2005 and September 2009
by searching for all women who were coded in our me-
dical system as being both pregnant with a normal deli-
very and also having any type of hepatitis. This initial list
was narrowed to women with hepatitis B by reviewing
laboratory results of each woman meeting these criteria
and selecting only those who were HBsAg positive. We
further defined our population’s level of infectivity by
evaluating for the presence of HBeAg, but includedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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our analysis.
Each inpatient delivery record was then reviewed to
evaluate the exposed newborn’s management and deter-
mine whether the infant had received HBIG (Hepatitis B
immunoglobulin) and HBV vaccine as recommended on
the first day of life. Pharmacy records were also queried
for a list of all infants to whom HBIG was dispensed.
These infants’ outpatient courses were then analyzed
to determine whether they went on to complete their
HBV vaccination series by 12 months (2 additional vac-
cines) and had subsequent serologic testing by 18 months
(HBsAg and anti-HBs). Only patients who demonstrated
ongoing care within the MHS, characterized by at least
four documented well baby appointments over the first
year of life and at least one encounter after 15 months,
were included in the study group.
In addition, we determined if exposure to HBV was
documented within the outpatient record and if the
child had seen our pediatric infectious disease (ID) spe-
cialists regarding the exposure. These variables were
compared by two-sided Fisher’s exact test to determine
the association with completing the recommended vac-
cine series and follow-up serologic testing.
Ethics
The study was approved by the Institutional Review
Boards at both Tripler Army Medical Center and the
Madigan Healthcare System.
Results
Both medical centers had very similar results. Cumula-
tively, from September 2005 to September 2009 there
were sixty-seven infants born to sixty-three HBsAg posi-
tive mothers; fourteen (22%) of these mothers were
HBeAg positive. Of the sixty infants born to HBsAg
positive mothers whose inpatient medical records were
available to review, 100% were given HBIG and their ini-
tial hepatitis B vaccination within 1 day of birth. Fifty-Table 1 Completion rates for recommended vaccinations and
Population
Maternal HBsAg + infants
Maternal HBsAg + infants with Ped ID referral
Maternal HBsAg + infants whose exposure was documented*
Maternal HBsAg+ / HBeAg + infants
Maternal HBsAg+ / HBeAg + infants with Ped ID referral
Maternal HBsAg+ / HBeAg + infants whose exposure was documented*
* Exposure documented within the infant’s electronic medical record.
Exposure to HBV infection and evaluation by a pediatric infectious disease specialis
association with completing the recommended vaccine series and completing follo
(HBsAg positive and HBSAg positive/HBeAg positive) who saw an infectious disease
were no statistically significant differences in vaccination rates amongst the differenone children were subsequently followed in the MHS.
92% completed their vaccine series by 12 months, but
only 10% received post-vaccination testing by 18 months.
In comparison, 94% of infants in the PHBPP received
recommended management at birth, and only 78% com-
pleted their vaccine series by 12 months. However, 56%
of those infants received post-vaccination testing by
18 months of age [1].
18% of the followed infants in this study were born to
mothers who were also HBeAg positive. Of those, 89%
completed their vaccination series and 33% were
followed up at 18 months for post-vaccination testing.
HBV exposure of the infants who were followed in our
system was never mentioned in more than half of their
outpatient medical records and documentation of the
exposure was not associated with serological testing
completion rates. However, the rates of post vaccination
serological testing were significantly higher for infants
born to HBeAg positive mothers and those referred to a
pediatric ID specialist despite national guideline recom-
mendations of follow-up testing for all exposed infants
(HBeAg positive and negative) (Table 1).
Discussion
This small study examines the care of HBV-exposed in-
fants within the United States MHS, which in contrast
to most hospital systems, has a unified global EMR.
Overall compliance with initial newborn management
and vaccination series completion at these two major
military medical centers far exceeded the national ave-
rage by comparison with the PHBPP, but most of our in-
fants did not have serologic testing by 18 months.
Although this could introduce a small systematic bias,
we used our schedule of receiving 3 vaccines by
12 months and obtaining serologic testing by 18 months
because this allowed us to compare our results to the
PHBPP who used the same model. In addition, the
American Academy of Pediatrics Committee on Infec-
tion Diseases recommends that infants born to HBsAg-post-vaccination serological testing
n Completed vaccination series Post vaccination serology
Percentage P value Percentage P value
51 92% 10%
9 89% (0.552) 33% (0.033)
24 92% (1.00) 13% (0.656)
9 89% (0.552) 33% (0.033)
4 100% (1.00) 75% (0.048)
7 100% (0.222) 43% (0.500)
t were compared using two-sided Fisher’s exact test to determine the
w-up serologic testing. Both patients who were HBeAg positive and all patients
specialist were more likely to have post-vaccination serologies checked. There
t groups.
Sainato et al. BMC Research Notes 2013, 6:338 Page 3 of 3
http://www.biomedcentral.com/1756-0500/6/338positive women should be tested for anti-HBs and
HBsAg after completion of the immunization series, at
9 to 18 months of age [4]. The highest rates of follow-up
testing among our population occurred in infants re-
ferred to a pediatric ID specialist, which suggests that in
the absence of a systematic method, subspecialty referral
facilitated the highest testing rates.
A limitation of our study is that there is now data to
support the use of lamivudine in pregnancy to reduce
viral load and thereby limit perinatal transmission [5].
Treatment with lamivudine was not standard of care at
our institutions for the cases analyzed from 2005–2009
and has only been adopted more recently. While this
may reduce transmission rates from mother to the child,
this does not change current vaccination or follow-up
serological testing recommendations of the offspring nor
alter the validity of our findings.
Provision of health care within the MHS is marked by
many unique challenges in managing infants born to
HBsAg positive mothers. There is frequent movement of
families, often internationally. Additionally, within the
MHS the inpatient and outpatient medical records are
not connected, so management plans documented at
birth are not routinely visible to outpatient clinics. An
indirect outcome of this study was identification that
HBV exposure is often not documented within the out-
patient medical record. Nevertheless, the vast majority
of our patients are still identified at birth and vaccinated
on time, evidencing that the challenges of a transient
population may be overcome with the help of a global
EMR. Instead, the primary issue needing improvement is
chronic management of a unique risk factor in the set-
ting of poor continuity of care, which has proven diffi-
cult to overcome by use of an EMR alone. We are not
aware of other published reports to-date that use an
EMR to ensure follow-up of HBV exposed infants. Our
data shows that HBV-exposed infants within the MHS
would benefit from a more systematic method of follow-
up, similar to the PHBPP, to ensure follow-up HBV sero-
logic testing is obtained as recommended.Abbreviations
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